Journal profile · Pharmacology & Pharmacy
Dissolution Technologies
ISSN 1521-298X · Dissolution Technologies Inc · UNITED STATES · Quarterly · Founded 1994
Dissolution Technologies: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.84; subscription journal; review about 3 months (community reports); community-reported acceptance: easy; 30 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Dissolution Technologies is published by Dissolution Technologies Inc and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Drug Solubulity and Delivery Systems, Crystallization and Solubility Studies and Analytical Methods in Pharmaceuticals, together about 44.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Dissolution Technologies is a peer reviewed quarterly publication reporting ongoing, useful information on dissolution testing. It provides an international forum for dissolution analysts to receive and exchange information on various dissolution topics.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics22.6%
- Crystallization and Solubility StudiesMaterials Science12%
- Analytical Methods in PharmaceuticalsChemistry10.2%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6%
- Pharmaceutical studies and practicesMedicine5.2%
- Human auditory perception and evaluationEngineering5.2%
- Analytical Chemistry and ChromatographyChemistry4.4%
- Protein purification and stabilityBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, Crossref, Science Citation Expanded®, Journal Citation Reports®/Science Edition, International Pharmaceutical Abstracts
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.84LetPub ·
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.26LetPub ·
- SNIP 2026-06
- 0.38LetPub ·
- h-index
- 28LetPub ·
- h-index
- 44OpenAlex ·
- i10-index
- 239OpenAlex ·
- 2-year mean citedness
- 0.73OpenAlex ·
- Self-citation rate
- 22.2%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 24LetPub ·
Articles by year OpenAlex count · 824 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 15 | 10 |
| 2025 | 30 | 26 | 14 |
| 2024 | 31 | 27 | 37 |
| 2023 | 32 | 27 | 69 |
| 2022 | 29 | 26 | 97 |
| 2021 | 30 | 28 | 131 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- book reviewThis book will be a valuable training or reference addition for everyone involved with development or application of dissolution tests for poorly soluble drugs.…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Peer review, Preprints
- AI use Simulations Plus and NVIDIA Collaborate to Scale GPU Accelerated, AI-Assisted Modeling Workflows
Simulations Plus, Inc. ("Simulations Plus" or the "Company"), a global leader in model-informed and AI accelerated drug development that advances biopharma innovation, announced the launch of a technical collaboration with NVIDIA focused on enabling graphics processing unit (GPU)-accelerated simulation and AI assisted workflows for... Full article Full issue
Source ↗Publisher website ·- Authorship
Disclaimer Model summary
All articles represent the view of the authors and not necessarily those of Dissolution Technologies.
Source ↗Publisher website ·- Peer review
Peer review Model summary
Dissolution Technologies is a peer reviewed quarterly publication reporting ongoing, useful information on dissolution testing.
Source ↗Publisher website ·- Preprints
Generic comparison studies will be published online only. Model summary
Dissolution Technologies Policy Update: Generic Comparison Studies to be Published Online Only
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Dissolution Technologies Inc
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1994
- ISSN
- 1521-298X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Dissolution Technologies
What CAS zone is Dissolution Technologies in?
In the 2025 upgraded edition of the CAS Journal Ranking, Dissolution Technologies is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Dissolution Technologies?
The latest impact factor listed by LetPub is 0.84; CiteScore 1.5, h-index 44.
How long does peer review take at Dissolution Technologies?
Authors report an average review time of about 3 months; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Dissolution Technologies?
According to LetPub and DOAJ records, Dissolution Technologies is indexed in SCIE and Scopus. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Dissolution Technologies open access, and what is the APC?
Dissolution Technologies is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .